Safety and Efficacy of Sovateltide (IRL-1620) in a Multicenter Randomized Controlled Clinical Trial in Patients with Acute Cerebral Ischemic Stroke.

Administration of tPA after 4.5 h of onset of stroke has shown no benefit [ 32 ] and involves the risk of hemorrhagic transformation, leading to highly significant morbidity and mortality [ 32 ].

also in 132,142 other papers

There is a clear trend towards complete recovery with sovateltide compared with saline, although it did not reach the level of statistical significance in all clinical scales; however, the OR was ≥ 2.0.

also in 19,460 other papers

These results show a trend towards complete recovery in the sovateltide group compared with the saline group, although it did not reach statistical significance in all the clinical outcome scales (Fig. 6 ).

also in 111,027 other papers